TL;DR
Get everyday helpers delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
The HAPPI MIND trial found that adults receiving nurse-led lifestyle support had a greater 12-month improvement in an estimated dementia risk score than those receiving usual care. The intervention included a smartphone app, but the supplied report does not give app-use figures or establish that the app itself drove the result.
A nurse-led dementia risk program produced a greater improvement in estimated risk scores than usual care at 12 months in an Australian trial involving 403 adults aged 45–65, according to results published in The Lancet Regional Health – Western Pacific. The program included personalized counseling and a smartphone app, but the report describes app use as limited and does not show that the app independently improved outcomes.
The pragmatic, cluster-randomized HAPPI MIND trial recruited participants through 31 general practices in Victoria and New South Wales. Thirteen practices delivered the intervention and 18 served as controls. Participants were eligible if they were 45 to 65, had at least two modifiable dementia risk factors, and had access to a smartphone or tablet. Of 430 people who consented, 403 completed baseline assessments: 201 in the intervention group and 202 in the control group.
Intervention participants were offered six nurse-led sessions: five during the first year and one at 24 months. Nurses provided tailored risk reports, helped participants set practical goals, used motivational interviewing, reviewed progress, and could refer patients to a general practitioner for further assessment or specialist care. The HAPPI MIND app was available for self-monitoring, goal tracking, and educational material. Control participants received a baseline risk screening, a report, and an educational booklet, then continued usual care without the structured sessions or app support.
The primary measure was change at 12 months in the ANU-ADRI, a questionnaire-based index estimating dementia risk from known risk and protective factors; a lower score indicates a more favorable profile. The report says scores improved for 56% of intervention participants and 44% of controls, with an adjusted between-group difference of 1.6 points. The supplied report says additional analyses were consistent with the main result, although the estimated effect was smaller after further adjustment for baseline factors. Twelve-month retention was 78% in the intervention arm and 88% in the control arm.
Testing Nurses’ Role in Prevention
The findings offer evidence that primary-care nurses can deliver structured, personalized prevention support across multiple risk areas, using existing patient relationships and routine clinic settings. This is relevant as health systems look for practical ways to address modifiable factors associated with later dementia, including vascular and lifestyle risks. The trial tested an approach that combines counseling with digital support rather than relying on an app alone.
The result is a change in an estimated risk profile, not evidence that participants avoided dementia or experienced a reduction in dementia diagnoses. The 12-month findings also do not establish which parts of the package mattered most: counseling, goal-setting, referrals, the app, or their combination. The modest score difference and differing retention rates are relevant when considering how well the intervention might work in routine care or for populations beyond those enrolled.
Popular right now
TCL T7 Series 85-Inch 4K 144Hz QLED Smart Google TV
Breville Bambino Espresso Machine, Brushed Stainless Steel (BES450BSS)
TCL QM64L 85-Inch QD-Mini LED 4K Smart Fire TV
As an affiliate, we earn on qualifying purchases.
How HAPPI MIND Was Designed
HAPPI MIND was designed as a pragmatic, two-arm cluster-randomized trial, with practices rather than individual patients assigned to the intervention or control group. Participants and providers knew which group they were in, while outcome assessors and analysts were blinded to allocation. This design tested delivery in general practice conditions, though patients needed a smartphone or tablet and had to be able to consent and communicate in English.
The study addresses a practical gap identified by the researchers: dementia-prevention trials have often tested multiple lifestyle changes, but evidence on delivering such programs through ordinary primary care remains limited. Australian practice nurses already support chronic disease prevention and management. HAPPI MIND assessed whether structured nurse counseling, supported by mobile health tools, could improve a risk index over the first year. The trial’s planned follow-up runs to 36 months; the results described here cover only the 12-month assessment.
“The intervention group showed significantly greater improvement on the ANU-ADRI than the control group.”
— The HAPPI MIND trial report
App Engagement and Longer-Term Effects
The available report does not provide a numerical measure of how often participants used the app, how usage differed between individuals, or whether app engagement was associated with changes in the risk score. It therefore cannot show whether the digital component added benefit beyond nurse-led sessions. The study tested the intervention as a package, not the app as a separate treatment.
It is also not yet clear whether the score difference persists, grows, or fades over time. The primary result is based on a questionnaire index of estimated risk, and these 12-month findings do not report a reduction in dementia cases. The supplied material notes secondary outcomes involving cognition, quality of life, cardiovascular risk, and behavioral or psychosocial measures, but does not give their results. The lower intervention-group retention—78%, compared with 88% in control—also warrants attention when interpreting the comparison.
Follow-Up Through 36 Months
Researchers plan to continue following participants through 36 months to examine whether the reported improvement lasts and how outcomes develop beyond the first year. Future results may also clarify secondary measures, including cognition, quality of life, and cardiovascular risk, as well as the role of engagement with the app. The current report does not specify when those analyses will be published.
For now, the evidence supports a limited conclusion: in this trial, the nurse-led program was associated with a greater 12-month improvement in an estimated dementia risk profile than the control condition. Longer follow-up and fuller reporting of app use and secondary outcomes will be needed to judge durability, the contribution of individual program components, and how readily the approach could be applied in other primary-care settings.
Key Questions
What did the HAPPI MIND trial find?
At 12 months, 56% of intervention participants and 44% of controls had improved ANU-ADRI scores. The adjusted difference between groups was reported as 1.6 points.
Did the study prove that the app prevents dementia?
No. The trial measured change in an estimated dementia risk index, not dementia diagnoses, and tested the app as part of a wider nurse-led program. The available report does not establish an independent effect from app use.
Who took part in the trial?
The analysis included 403 adults aged 45–65 recruited through 31 general practices in Victoria and New South Wales. Participants had at least two modifiable dementia risk factors and access to a smartphone or tablet.
What support did intervention participants receive?
They were offered six nurse-led sessions, personalized risk reports, goal-setting, progress reviews, and access to the HAPPI MIND app for tracking and education. Nurses could also refer participants for further clinical assessment.
What remains unknown?
The report does not quantify app engagement or show which parts of the program contributed to the score change. Longer-term effects and several secondary outcomes are also not provided in the 12-month results; follow-up is planned through 36 months.
Source: news-medical.net
